Similarly, the MAPK signaling pathway plays a critical role in depression, with the MAPK-CREB1-BDNF signaling axis, a branch of the MAPK pathway, reducing depressive symptoms in mice by modulating hippocampal neuronal damage (70). Here, BDNF is linked to depressive symptom measurement.